ObsEva Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Liquidation

ObsEva General Information

Description

ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.

Contact Information

Website
www.obseva.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Chemin des Aulx, 12
  • Plan-les-Ouates
  • 1228 Geneva
  • Switzerland
+41 022
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Chemin des Aulx, 12
  • Plan-les-Ouates
  • 1228 Geneva
  • Switzerland
+41 022

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ObsEva Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Liquidation Completed Generating Revenue
10. Debt - General 12-Oct-2021 Completed Generating Revenue
9. 2PO 03-Sep-2020 Cancelled Generating Revenue
8. PIPE 03-Sep-2020 Completed Generating Revenue
7. General Corporate Purpose 08-Aug-2019 Completed Generating Revenue
6. Secondary Transaction - Open Market 31-Dec-2017 Completed Generating Revenue
5. PIPE 13-Oct-2017 Completed Generating Revenue
4. IPO 26-Jan-2017 Completed Generating Revenue
3. Early Stage VC (Series B) 23-Nov-2015 $60.5M $95.1M Completed Generating Revenue
2. Early Stage VC (Series A) 29-Aug-2013 $34.6M $34.6M Completed Startup
To view ObsEva’s complete valuation and funding history, request access »

ObsEva Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therap
Drug Discovery
Geneva, Switzerland
6 As of 2022

Allschwil, Switzerland
 

Wayne, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ObsEva Competitors (13)

One of ObsEva’s 13 competitors is Idorsia Pharmaceuticals, a Corporation company based in Allschwil, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Idorsia Pharmaceuticals Corporation Allschwil, Switzerland
Aclaris Therapeutics Formerly VC-backed Wayne, PA
Roivant Sciences Formerly PE-Backed New York, NY
Adienne Corporation Lugano, Switzerland
Evotec Formerly PE-Backed Hamburg, Germany
You’re viewing 5 of 13 competitors. Get the full list »

ObsEva Patents

ObsEva Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022101495-A1 Compositions and methods for the treatment or prevention of preterm labor Inactive 16-Nov-2020
AU-2021218895-A1 Biomarkers for oxytocin receptor antagonist therapy Inactive 10-Feb-2020
CA-3167121-A1 Biomarkers for oxytocin receptor antagonist therapy Pending 10-Feb-2020
EP-4103750-A1 Biomarkers for oxytocin receptor antagonist therapy Inactive 10-Feb-2020
US-20230102503-A1 Biomarkers for oxytocin receptor antagonist therapy Inactive 10-Feb-2020 C12Q1/6883
To view ObsEva’s complete patent history, request access »

ObsEva Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ObsEva ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view ObsEva’s complete esg history, request access »

ObsEva FAQs

  • When was ObsEva founded?

    ObsEva was founded in 2012.

  • Where is ObsEva headquartered?

    ObsEva is headquartered in Geneva, Switzerland.

  • What is the size of ObsEva?

    ObsEva has 6 total employees.

  • What industry is ObsEva in?

    ObsEva’s primary industry is Drug Discovery.

  • Is ObsEva a private or public company?

    ObsEva is a Private company.

  • What is ObsEva’s current revenue?

    The current revenue for ObsEva is .

  • How much funding has ObsEva raised over time?

    ObsEva has raised $384M.

  • Who are ObsEva’s competitors?

    Idorsia Pharmaceuticals, Aclaris Therapeutics, Roivant Sciences, Adienne, and Evotec are some of the 13 competitors of ObsEva.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process